US Patent 7825127 Method for treating cancer

Patent 7825127 was granted and assigned to Takeda Pharmaceutical Company on November, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Takeda Pharmaceutical Company

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7825127

Patent Inventor Names

Yoshikazu Ohta0

Shinji Takagi0

Date of Patent

November 2, 2010

Patent Application Number

12005883

Date Filed

December 27, 2007

Patent Primary Examiner

‌

James D. Anderson

Patent abstract

The present invention provides a method for treating cancer, which includes selecting a patient coexpressing HER2 and HER3, and administering an effective amount of a HER2 inhibitor to the patient.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7825127 Method for treating cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API